NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 201 filers reported holding NOVOCURE LTD in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $358,000 | +67.3% | 1,612 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $214,000 | -85.4% | 1,612 | -81.0% | 0.00% | -88.9% |
| Q4 2020 | $1,464,000 | +59.3% | 8,462 | +2.6% | 0.02% | +50.0% |
| Q3 2020 | $919,000 | -72.4% | 8,250 | -85.3% | 0.01% | -73.9% |
| Q2 2020 | $3,331,000 | -12.1% | 56,160 | -0.2% | 0.05% | -23.3% |
| Q1 2020 | $3,790,000 | -12.0% | 56,270 | +0.5% | 0.06% | +39.5% |
| Q4 2019 | $4,305,000 | +1.7% | 56,010 | -1.0% | 0.04% | -6.5% |
| Q3 2019 | $4,233,000 | +48.4% | 56,600 | +25.5% | 0.05% | +48.4% |
| Q2 2019 | $2,852,000 | +31.2% | 45,100 | 0.0% | 0.03% | +29.2% |
| Q1 2019 | $2,173,000 | +3004.3% | 45,100 | +2047.6% | 0.02% | +2300.0% |
| Q4 2018 | $70,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |